Analyst Reco. Inari Medical, Inc.

Equities

NARI

US45332Y1091

Market Closed - Nasdaq Other stock markets 04:00:00 2024-07-05 pm EDT			5-day change	1st Jan Change
51.39 ^USD	+2.76%		+6.73%	-20.84%

Jul. 01	Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell 3000E Value Index	CI
Jul. 01	Inari Medical, Inc.(NasdaqGS:NARI) dropped from Russell 3000 Value Index	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Inari Medical Insider Sold Shares Worth $1,741,579, According to a Recent SEC Filing	Jun. 20	MT
Inari Medical Insider Sold Shares Worth $1,863,977, According to a Recent SEC Filing	May. 20	MT
Inari Medical Insider Sold Shares Worth $1,619,047, According to a Recent SEC Filing	May. 03	MT
Truist Securities Cuts Inari Medical's Price Target to $52 From $61, Reiterates Hold Rating	Mar. 22	MT
Piper Sandler Downgrades Inari Medical to Neutral From Overweight, Cuts Price Target to $55 From $85	Feb. 29	MT
Morgan Stanley Lowers Price Target on Inari Medical to $75 From $83, Keeps Overweight Rating	Feb. 29	MT
Needham Initiates Inari Medical With Buy Rating, $72 PT; Notes 'Attractive' Valuation, Expects 'Rapid' Improvement in Margin, Earnings in 2025, Beyond	Jan. 23	MT
Truist Securities Adjusts Price Target on Inari Medical to $70 From $65, Maintains Hold Rating	Dec. 22	MT
Truist Securities Adjusts Inari Medical's Price Target to $65 From $70, Keeps Hold Rating	23-07-19	MT
Baird Initiates Inari Medical With Outperform Rating, $79 Price Target	23-07-19	MT
Truist Securities Adjusts Price Target on Inari Medical to $70 From $68, Keeps Hold Rating	23-04-18	MT
Canaccord Genuity Adjusts Price Target on Inari Medical to $80 From $77, Maintains Buy Rating	23-02-28	MT
Canaccord Genuity Adjusts Price Target on Inari Medical to $77 From $76, Maintains Buy Rating	23-02-21	MT
Truist Securities Adjusts Inari Medical's Price Target to $65 From $75, Maintains Hold Rating	23-01-31	MT
Jefferies Adjusts Inari Medical's Price Target to $91 From $89, Maintains Buy Rating	23-01-12	MT
Morgan Stanley Cuts Price Target on Inari Medical to $83 From $95, Affirms Overweight Rating	23-01-06	MT
Truist Securities Adjusts Price Target on Inari Medical to $75 From $84, Maintains Hold Rating	22-12-20	MT
Morgan Stanley Adjusts Price Target on Inari Medical to $95 From $93, Maintains Overweight Rating	22-11-03	MT
Berenberg Bank Adjusts Inari Medical Price Target to $86 From $85, Maintains Buy Rating	22-11-03	MT
BTIG Trims Inari Medical's Price Target to $97 From $100, Maintains Buy Rating	22-10-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Inari Medical, Inc.

Equities

NARI

US45332Y1091

Analyst Reco.

Filters